"It is time to challenge current treatment practices—namely, using inhibitors and
antagonists alone—and to develop immunoresolvents as agonists of resolution pharmacology."

- Professor Charles Serhan, Harvard Medical School. FASEB J (2017).

Resolvins: Agonists of Inflammation Resolution

Discovered by Dr. Serhan and his colleagues at Harvard, Resolvins are a novel class of "Immunoresolvents" that resolve inflammation, enhance clearance of debris (phagocytosis), and promote healing. Unlike standard anti-inflammatory drugs that inhibit immune function, Resolvins are agonists of resolution that restore homeostasis without immune suppression.